Back to DE D. E. Shaw & Co., Inc.

URGNURGN
Showing 6 of 10 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in UROGEN PHARMA LTD

D. E. Shaw & Co., Inc. holds 1.1M shares of URGN (UROGEN PHARMA LTD), worth $42.2M as of 2026-Q2. The position was increased (+12.0% shares). URGN represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$42.2M

Current Shares

1.1M

Total Value Change

+$42.2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+12.0%
$42.2M0.0%$36.80
33
2026-Q1
Increased
1M
+6.3%
$18.4M0.0%$18.82
30
2025-Q4
Increased
962,624
+8.3%
$22.5M0.0%$23.17
31
2025-Q3
Increased
888,933
+3140.5%
$17.7M0.0%$19.14
46
2025-Q2
New
27,432
-
$375,8180.0%$13.49
33
2024-Q3
Exited
0
-100.0%
$00.0%$12.90
0

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used